Immunomedics Inc (NASDAQ:IMMU)

4.10
Delayed Data
As of May 22
 +0.02 / +0.49%
Today’s Change
3.08
Today|||52-Week Range
5.48
-14.58%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$381.3M

Company Description

Immunomedics, Inc. is a biopharmaceutical company, which engages in the business of researching, developing, manufacturing and marketing biopharmaceutical products. The company primarily focused on the development of monoclonal, antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases. It markets and sells its products in the U.S. and throughout Europe. Immunomedics was founded by David M. Goldenberg in July 1982 and is headquartered in Morris Plains, NJ.

Contact Information

Immunomedics, Inc.
300 The American Road
Morris Plains New Jersey 07950
P:(973) 605-8200
Investor Relations:

Employees

Shareholders

Individual stakeholders7.21%
Mutual fund holders25.18%
Other institutional18.99%

Top Executives

David M. GoldenbergChairman, Chief Scientific & Medical Officer
Cynthia L. SullivanPresident, Chief Executive Officer & Director
Peter P. PfreundschuhChief Financial Officer & Vice President-Finance
Phyllis ParkerSecretary

To view my watchlist

Not a member yet?

Sign up now for a free account